State Street’s NexImmune, Inc. Common Stock NEXI Stock Holding History

State Street’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-917	Closed	-$4.58K	–	4515
2023 Q3	$4.58K	Hold	917	–	–	﹤0.01%	4539
2023 Q2	$6.39K	Hold	917	–	–	﹤0.01%	4656
2023 Q1	$8.71K	Hold	917	–	–	﹤0.01%	4752
2022 Q4	$5.57K	Hold	917	–	–	﹤0.01%	4828
2022 Q3	$13K	Hold	917	–	–	﹤0.01%	4875
2022 Q2	$37K	Sell	917 -7,644	-89%	-$473K	﹤0.01%	4784
2022 Q1	$901K	Buy	8,561 +749	+10%	+$55K	﹤0.01%	3844
2021 Q4	$900K	Buy	7,812 +1,322	+20%	+$318K	﹤0.01%	3839
2021 Q3	$2.46M	Buy	6,490 +2,661	+69%	+$892K	﹤0.01%	3556
2021 Q2	$1.56M	Buy	3,829 +1,891	+98%	+$871K	﹤0.01%	3587
2021 Q1	$925K	Buy	+1,938	New	+$1.05M	﹤0.01%	3639

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street's NEXI Position: Q4 2023 in Review

State Street sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 917 shares — an estimated $4.58K sold.

State Street first reported a position in NEXI in Q1 2021 and held it in 11 quarters. The position peaked at $2.46M in Q3 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

State Street reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State Street sold 917 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $4.58K.
State Street first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
State Street's NexImmune, Inc. Common Stock position peaked at $2.46M in Q3 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.